نتایج جستجو برای: allogeneic bone graft

تعداد نتایج: 393210  

2011
Sydney X. Lu Lucy W. Kappel Anne-Marie Charbonneau-Allard Renée Atallah Amanda M. Holland Claire Turbide Vanessa M. Hubbard Jimmy A. Rotolo Marsinay Smith David Suh Christopher King Uttam K. Rao Nury Yim Johanne L. Bautista Robert R. Jenq Olaf Penack Il-Kang Na Chen Liu George Murphy Onder Alpdogan Richard S. Blumberg Fernando Macian Kathryn V. Holmes Nicole Beauchemin Marcel R. M. van den Brink

BACKGROUND Allogeneic bone marrow transplantation (allo-BMT) is a potentially curative therapy for a variety of hematologic diseases, but benefits, including graft-versus-tumor (GVT) activity are limited by graft-versus-host-disease (GVHD). Carcinoembryonic antigen related cell adhesion molecule 1 (Ceacam1) is a transmembrane glycoprotein found on epithelium, T cells, and many tumors. It regula...

Journal: :international journal of hematology-oncology and stem cell research 0
ardeshir ghavamzadeh hematology- oncology and stem cell research center, shariati hospital, tehran university of medical sciences, tehran, iran kamran alimogaddam hematology- oncology and stem cell research center, shariati hospital, tehran university of medical sciences, tehran, iran mohammad jahani hematology- oncology and stem cell research center, shariati hospital, tehran university of medical sciences, tehran, iran amirali hamidieh hematology- oncology and stem cell research center, shariati hospital, tehran university of medical sciences, tehran, iran seyed asadollah mousavi hematology- oncology and stem cell research center, shariati hospital, tehran university of medical sciences, tehran, iran masoud iravani hematology- oncology and stem cell research center, shariati hospital, tehran university of medical sciences, tehran, iran

introduction: this review reports the current results of hematopoietic stem cell transplantation (hsct) in patients who had received transplantation in the hematology-oncology and sct research center, tehran, iran. methods: in iran, from 1991 through 2010, a total of 3170 hematopoietic stem cell transplantation have been carried out. the male/female patient ratio was 1909/1261 with a median age...

Journal: :Hong Kong medical journal = Xianggang yi xue za zhi 2004
S Y Ma A K W Lie W Y Au C S Chim Y L Kwong R Liang

OBJECTIVE To present an institution's 2-year experience of non-myeloablative allogeneic stem cell transplantation among Chinese patients. DESIGN Retrospective study. SETTING Bone marrow transplantation unit at a university hospital, Hong Kong. PATIENTS Ten patients with multiple myeloma who received non-myeloablative allogeneic stem cell transplantation between March 2000 and October 2002...

Journal: :international journal of hematology-oncology and stem cell research 0
soudabeh hosseini department of hematology and blood transfusion, school of allied medical sciences, iran university of medical sciences, tehran, iran shahla ansari hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran parvaneh vosough hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran gholamreza bahoush hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran morteza shamsizadeh department of medical-surgical nursing, school of nursing and midwifery, hamadan university of medical sciences, hamadan, iran mitra mehrazma department of pathology, iran university of medical sciences, tehran, iran

isolated extramedullary relapse of chronic myelogenous leukemia (cml) after allogeneic stem cell transplant is rare. there is a case report of a child who developed a granulocytic sarcoma of the maxillary and sphenoid sinuses and lumbosacral spinal cord mass 18 months after allogeneic bone marrow transplant for cml. he was presented with per orbital edema and neurological deficit of lower extre...

2012
Joseph Leventhal Yiming Huang Hong Xu Idona Goode Suzanne T Ildstad

Graft-versus-host disease is one of the major transplant-related complications in allogeneic hematopoietic stem cell transplantation. Continued efforts have been made to prevent the occurrence of severe graft-versus-host disease by eliminating or suppressing donor-derived effector T cells. Conventional immunosuppression does not adequately prevent graft-versus-host disease, especially in mismat...

Journal: :international journal of hematology-oncology and stem cell research 0
ardeshir ghavamzadeh hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran roshanak derakhshandeh hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran arash jalali hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran ali jafarpour hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran kamran alimoghaddam hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran amirali hamidieh hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran

introductio: hematopoietic stem cell transplants (hsct) are considered as treatment options for patients with solid tumors. transplant numbers have changed significantly over the last decade. we have done autologous and allogeneic hsct for treatment of solid tumor patients in our center. methods: in order to show the transplant effect on solid tumor treatment, we collected data from 71 patients...

Journal: :Blood 2008
William J Murphy

creased risks of deleterious host-initiated and donor-initiated innate and adaptive immune responses. Administration of CpC oligonucleotides resulted in increased infiltration of lymphoid organs and Peyer patches by donor T cells in allogeneic recipients. The augmented alloreactivity was made manifest as increased GVHD and graft rejection, with the donor and host T cells activated by host-type ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید